David R. Gandara, MD, talks about the benefits of using Cyramza® (ramucirumab) plus docetaxel verus docetaxel alone in 2nd line NSCLC at Annual Meeting 2018.
Benefits of using ramucirumab plus docetaxel in 2nd line NSCLC
David R. Gandara, MD, talks about the benefits of using Cyramza® (ramucirumab) plus docetaxel verus docetaxel alone in 2nd line NSCLC at Annual Meeting 2018.